131 related articles for article (PubMed ID: 3859415)
1. Further evaluation of bimolane and analogs as potential antitumor agents.
Ren YF; Otter GM; Schmid FA
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):493-7. PubMed ID: 3859415
[TBL] [Abstract][Full Text] [Related]
2. Effect of AT1727 on growth and metastasis of murine tumours.
Li XT; Hutchinson GE; Pym BA; Finch M; Hellmann K
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):283-7. PubMed ID: 6681774
[TBL] [Abstract][Full Text] [Related]
3. Combination of radiation and razoxane (ICRF 159) in vivo.
Hellmann K; Grimshaw MB; Hutchinson GE
Int J Radiat Oncol Biol Phys; 1978; 4(1-2):109-13. PubMed ID: 632139
[No Abstract] [Full Text] [Related]
4. [Effects of bimolane on size, metastases and cyclic AMP levels of Lewis lung carcinoma].
Huang KW; Fu NW; Ren YF
Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):69-71. PubMed ID: 6326466
[No Abstract] [Full Text] [Related]
5. Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943).
Woodman RJ; Cysyk RL; Kline I; Gang M; Venditti JM
Cancer Chemother Rep; 1975; 59(4):689-95. PubMed ID: 1175163
[TBL] [Abstract][Full Text] [Related]
6. ICRF-187 in clinical oncology.
Poster DS; Penta JS; Bruno S; Macdonald JS
Cancer Clin Trials; 1981; 4(2):143-6. PubMed ID: 6788388
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between radiation sensitization and DNA damage by bimolane].
Zhang YP; Chen YN; Fan GC; Xia SX
Zhongguo Yao Li Xue Bao; 1987 Mar; 8(2):177-80. PubMed ID: 2959009
[No Abstract] [Full Text] [Related]
8. ICRF-159: current status and clinical prospects.
Bellet RE; Rozencweig M; Von Hoff DD; Penta JS; Wasserman TH; Muggia FM
Eur J Cancer (1965); 1977 Nov; 13(11):1293-8. PubMed ID: 590286
[No Abstract] [Full Text] [Related]
9. [The cytokinetic effects of bimolane (AT-1727) on S180 cells].
Lin C; Zhang TM
Yao Xue Xue Bao; 1982 Sep; 17(9):654-7. PubMed ID: 7158349
[No Abstract] [Full Text] [Related]
10. Bimolane: structure determination indicates anticancer activity is attributable to ICRF-154.
Camerman N; Hempel A; Camerman A
Science; 1984 Sep; 225(4667):1165-6. PubMed ID: 6474171
[TBL] [Abstract][Full Text] [Related]
11. ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
Holm B; Jensen PB; Sehested M
Cancer Chemother Pharmacol; 1996; 38(3):203-9. PubMed ID: 8646793
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the cytotoxic and genotoxic effects of ICRF-154 and bimolane, two catalytic inhibitors of topoisomerase II.
Vuong MC; Hasegawa LS; Eastmond DA
Mutat Res; 2013 Jan; 750(1-2):63-71. PubMed ID: 23000430
[TBL] [Abstract][Full Text] [Related]
13. [Reproductive toxicity of bimolane in mice and rabbits].
Chen LJ; Wang MY; Liu MZ
Zhongguo Yao Li Xue Bao; 1989 Nov; 10(6):557-60. PubMed ID: 2641857
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological studies on bimolane (AT-1727), a new antineoplastic agent (author's transl)].
Zhang TM; Chen ZY; Lin C
Yao Xue Xue Bao; 1980 Oct; 15(10):577-83. PubMed ID: 7257778
[No Abstract] [Full Text] [Related]
15. [Antineoplastic action and toxicity of probimane and its effect on immunologic functions in mice].
Zhang TM; Wang MY; Wang QD; Ren YF
Zhongguo Yao Li Xue Bao; 1987 Jul; 8(4):369-74. PubMed ID: 3502223
[No Abstract] [Full Text] [Related]
16. Stereoselective effects of cis- and trans-cyclopropylbis (dioxopiperazines) related to ICRF-159 on metastases of hamster lung adenocarcinoma.
Witiak DT; Lee HJ; Goldman HD; Zwilling BS
J Med Chem; 1978 Dec; 21(12):1194-7. PubMed ID: 722727
[TBL] [Abstract][Full Text] [Related]
17. Studies in mice treated with ICRF-159 combined with daunorubicin or doxorubicin.
Giuliani F; Casazza AM; Di Marco A; Savi G
Cancer Treat Rep; 1981; 65(3-4):267-76. PubMed ID: 6263470
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models.
Narita T; Yaguchi S; Komatsu T; Takase M; Hoshino A; Inaba M; Tsukagoshi S
Cancer Chemother Pharmacol; 1990; 26(3):193-7. PubMed ID: 2357766
[TBL] [Abstract][Full Text] [Related]
19. Reduction of chronic doxorubicin cardiotoxicity in beagle dogs by bis-morpholinomethyl derivative of razoxane (ICRF-159).
Herman EH; Ferrans VJ; Bhat HB; Witiak DT
Cancer Chemother Pharmacol; 1987; 19(4):277-81. PubMed ID: 3594714
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.
Fujimoto S; Ogawa M
Cancer Chemother Pharmacol; 1982; 8(2):157-62. PubMed ID: 7105379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
